Pharmaceuticals & Healthcare Products
186 posts · page 1 of 8
India’s new CDSCO guidelines for expert panels in drug and device approvals and their impact on innovation
India's CDSCO guidelines aim to streamline drug approvals, boosting innovation.
Growth drivers behind India’s pharma market growing 8.4% in FY25, especially in chronic therapies
India's pharma market thrives, driven by chronic therapy demand.
Lessons from the price erosion of empagliflozin post patent expiry in India
Empagliflozin's price drop reveals crucial market dynamics.
India crossing 30 billion dollars in pharma exports for FY25 and what it means for global competitiveness
India's pharma exports soar, boosting global market presence.
The pharma export portal shift and its implications for Indian exporters
India's pharma export portal shift reshapes global trade strategies.
How the streamlining of medical device clearance rules is changing regulatory timelines in Indian pharma
New rules are speeding up medical device approvals in India.
Market behaviour in April 2025 and how price hikes and chronic therapies drove IPM growth
April 2025 saw dramatic price hikes fueling IPM growth.
Reduced regulatory violations in Indian pharma as USFDA observation rates decline
Indian pharma sees fewer USFDA violations, boosting confidence.
The rise of anti-obesity drugs like GLP-1 therapies in shaping India’s emerging markets
GLP-1 therapies are transforming India's obesity treatment landscape.
Global companies setting up tech innovation centres in India and what it means for R&D
Global firms are boosting R&D by launching tech hubs in India.
State-level pharma and medical device policies and their role in attracting investment
State policies shape the future of pharma investments significantly.
Government proposals to ease clinical trial rules and what it means for R&D and innovation
New rules could boost innovation in clinical trials significantly.
The impact of pharma-grade sugar export policies on domestic supply and global trade
Pharma-grade sugar policies reshape markets and trade dynamics.
Large acquisitions in Indian pharma and what consolidation means for competition and scale
Mergers in Indian pharma reshape competition and market dynamics.
Challenges and volatility in pharma stocks in H1 2025 and the impact on investor sentiment
Pharma stocks faced turmoil, shaking investor confidence.
India’s dependence on imported APIs and strategies for boosting local manufacturing
India seeks to reduce reliance on imported APIs through local strategies.
Adoption of Indian Pharmacopoeia by international markets and its significance for trade
Indian Pharmacopoeia boosts global trade in pharmaceuticals.
How regulatory clarity in biologics approval can open new growth frontiers in Indian pharma
Regulatory clarity can boost India's biologics sector significantly.
The state of clinical trials in India and recent reforms to attract global studies
India's reforms boost clinical trials, attracting global interest.
Policy environment around medical devices and incentives for growth
Navigating policies can fuel medical device innovation and growth.
Pricing pressures versus value growth in therapy segments such as cardiac and diabetes
Balancing pricing pressures with value growth in therapies.
How Indian pharma companies are building strength in immunotherapy and biologics
Indian pharma companies are innovating in immunotherapy breakthroughs.
The rising role of specialty drugs and biologics in India’s export mix
India's specialty drugs are transforming global healthcare exports.
The future of Indian obesity drug pipelines and the global race to develop novel molecules
India's obesity drug pipeline is vital for global health innovation.